Assessing epigenetic silencing of a metastasis-suppressing gene in cell-free DNA provides prognostic information for non-small cell lung cancer, according to a recent study led by researchers from the University of Athens in Greece.
Assessing epigenetic silencing of a metastasis-suppressing gene in cell-free DNA provides prognostic information for non-small cell lung cancer, according to a recent study led by researchers from the University of Athens in Greece.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.